Elife logo

編集者

目次

    更新日: 2024.10.03
    Medical information: Dutasteride AV/ZA (0.5mg)

    Important safety information including dosage, side effects, and precautions of Dutasteride AV/ZA (0.5mg).

    Image assets%2Ff84ab7e7f0af4058b5c5065e08214eae%2Fcb5b33d3f10442bea5fc9fa297c79815

    Dosage & Administration

    ・Take the medicine with water, without breaking the tablet.


    ・Take once daily at the same time each day after meals, for increased absorption effects.


    ・If you forget to take the pill, do not take two pills the next time. Take one pill as usual.

    Side Effects

    If you experience any of the following side effects, discontinue use of the medication and seek appropriate medical attention.


    ・Liver problems, jaundice, ejaculation, erectile dysfunction, and sexual dysfunction.


    However, since decreased libido is often linked to psychological factors, it’s unlikely to be a side effect unless the symptoms appear right after taking the medication.

    Precautions

    ・Only men can use Dutasteride


    ・Do not use if you have a history of hypersensitivity or allergies to this medication.


    ・If you plan to be screened for prostate cancer, please let your doctor know that you are taking Dutasteride.


    ・If you are using other medicines, please consult your doctor. When you visit other medical institution, inform them that you are taking AGA medicine.


    ・In case of emergencies, such as the occurrence of serious side effects, stop taking the medication and go to the nearest medical institution.

    Approval status in Japan

    ・In Japan, Dutasteride was approved in 2015 for the treatment of AGA (Androgenetic Alopecia).


    *Medicines prescribed in this department are not covered by the Adverse Reactions Relief System.

    Means of acquisition

    ・Our affiliated clinic physicians purchase Dutasteride AV/ZA 0.5 mg via a domestic pharmaceutical distributor.

    Information on safety and approval in other countries

    ・Dutasteride is approved by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea for the treatment of AGA (male pattern baldness).